Clover Health Investments, Corp. (CLOV) Stock Analysis

Company Overview

Clover Health Investments, Corp. (CLOV) is capitalised at $2.26B on the latest close. It is classified in the Healthcare Plans industry, within the Healthcare sector. Headcount on file is 724.

CLOV last closed at $4.26 on September 4, 2026. The close was unchanged from the previous session. Over the past 52 weeks the price has ranged from $1.58 to $5.59. The latest close sits 169.3% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.92B. That is +40.34% against the prior fiscal year, when revenue was $1.37B. The same year closed with a net loss of $85.55M. The reported profit margin is −0.74%. That is 1.9 percentage points below the Healthcare Plans median of 1.18%. Earnings per share on a trailing basis come to −0.05.

Across the 4 fiscal years on file, revenue moves from $1.10B in 2022 to $1.92B in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 28.37. Measured against sales, the shares trade at 0.91 times revenue. On price-to-sales that is 107.73% above the Healthcare Plans median of 0.44. 11 Healthcare Plans companies report these metrics, and the medians quoted come from that group.

The reported beta is 2.48. Daily returns over the trailing 6 years annualize to a volatility of 86.5%. The trailing one-year price return is +58.18%. Across 5 years the annualized return works out at −13.60%.

Growth & Income

The record shows no dividend for CLOV.

Across the complete calendar years on file, 2024 returned +230.88% and 2021 returned −77.82%. Of the 5 complete calendar years on file, 2 finished higher. 2026 is still running; the price is +81.06% year to date.